Did you miss this years World EPA Congress? Checkout this free, downloadable PDF that provides a summary of the PRECISIONadvisors presentation "Gene Therapies Market Access: Lessons From the Past, Future Best Practice", as well as other key takeaways from the conference including initiatives to support improved patient access, access challenges, and more.
Why are some drugs that may be demonstrated as cost-effective not being recommended for reimbursement? PRECISIONadvisors Richard Macaulay and his co-author have published this influential study, uncovering that the NICE ICER thresholds have declined by 42.9% in real terms since 2004 (without accounting for inflation).
China, the second largest pharmaceutical market in the world (valued at more than $150 billion), is experiencing a paradigm shift characterized by a booming economy, a growing middle class, and an increasingly aged population with rising disease rates. By reviewing recent changes to the Chinese pricing and market access landscape, PRECISIONadvisors’ Andrea Ong and Laura Montani discuss how manufacturers can capitalize on this booming market.
With the Brexit transition period behind us, the healthcare landscape in the UK is poised for change. Precision's Dimitrios Tzaras & David Carr discuss 8 regulatory, HTA and commercial initiatives likely to shape UK market access in 2021.
LEADING BIO-ENGINEERING AND MANUFACTURING SERVICES FIRM CATALYZES THE LAUNCH OF PRECISION’S CELL AND GENE THERAPY OFFERING—'PRECISION ADVANCE’—ADDRESSING THE UNIQUE CHALLENGES OF CELL & GENE THERAPY INNOVATORS, FROM DEVELOPMENT THROUGH COMMERCIALIZATION
The gene therapy market is still in its infancy but poised for significant growth, with an approximate 25% increase in therapies in the pipeline as compared to 2018. However, the launch of a gene therapy is an event with limited case examples to follow and numerous unique considerations.
What are the most important market dynamics to ensure the success of your gene therapy?
COVID-19 has brought an undeniable impact on the healthcare landscape. Are you prepared for the coming dynamic healthcare coverage shifts?
Precision's David Carr examines the 3 main drivers for change in the health care industry in the 2020's, and how health care players can and should adapt.
Read our interview with Olaf Koester on significant changes to the Patented Medicines Regulations set to go into effect July 1, 2020.